✦ LIBER ✦

A pilot, open-labelled, phase II study using oral ribavirin in the treatment of patients with chronic active hepatitis B

✍ Scribed by Tong, Myron J.; Hwang, Shinn-Jang; Lefkowitz, Michele; Lee, Shou-Dong; Co, Ruth L.; Lo, Kwang-Juei

Book ID: 123571045
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 534 KB
Volume: 3
Category: Article
ISSN: 0928-0197
DOI: 10.1016/0928-0197(94)00051-U

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with daily consensus interfero

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study

✍ Markus Cornberg; Johannes Hadem; Eva Herrmann; Frank Schuppert; Hartmut H.-J. Sc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 551 KB

Efficacy of treatment with lamivudine in

Efficacy of treatment with lamivudine in patients with chronic active E-minus variant hepatitis B virus infection: A nonrandomized, open-label study

✍ Gaetano Scotto; Vincenzina Fazio; Fausto Campanozzi; Antonio D'Adduzio 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 630 KB

A pilot study of add-on oral hypoglycemi

A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin

✍ Hsu, Ching-Sheng; Hsu, Shih-Jer; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Ch 📂 Article 📅 2014 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 295 KB

43 A multicenter, randomized, open-label

43 A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of chinese patients with HBeAg+VE chronic hepatitis B

✍ H. Zhao; C.-W. Si; L. Wei; M.-B. Wan; Y.-K. Ying; J.-L. Hou; J.-Q. Niu; G.-Q. Wa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 257 KB

A phase III study of the safety and effi

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

✍ Yves Benhamou; Nezam H. Afdhal; David R. Nelson; Mitchell L. Shiffman; Deanine G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 2 views

Pegylated interferon (peg-IFN) and ribavirin (RBV) are effective in eradicating the hepatitis C virus in more than half of patients. However, anemia arising from RBV-induced hemolysis can prompt dose reductions and lower sustained virologic response (SVR) rates. In early clinical trials, Viramidine

1152 A phase II study in China of the sa

1152 A phase II study in China of the safety & antiviral activity of entecavir in adults with chronic hepatitis B infection

✍ YAO, G; XU, D; WANG, B; ZHOU, X; LEI, B; ZHANG, D; XU, D; LIU, J; MACDONALD, L 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB